Andrea Vereda
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age.
Journal: NEJM evidence
Published: February 06, 2024
Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial.
Journal: Clinical and translational allergy
Published: April 05, 2023
Children and caregiver proxy quality of life from peanut oral immunotherapy trials.
Journal: Clinical and translational allergy
Published: July 05, 2022
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.
Journal: The Journal of allergy and clinical immunology
Published: February 22, 2021
Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland.
Journal: PloS one
Published: January 18, 2021
Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Journal: Allergy
Published: December 08, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 18, 2020
Allergy to Peanuts imPacting Emotions And Life (APPEAL): the impact of peanut allergy on children, adolescents, adults and caregivers in France.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: June 05, 2020
Psychosocial and productivity impact of caring for a child with peanut allergy.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: May 13, 2020
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
Journal: The Lancet. Child & adolescent health
Published: April 29, 2020
APPEAL-2: A pan-European qualitative study to explore the burden of peanut-allergic children, teenagers and their caregivers.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: March 20, 2020
Last Updated: 09/26/2026